key: cord-0993152-hqvujid3
authors: Tuncer, Gulsah; Surme, Serkan; Bayramlar, Osman F; Karanalbant, Hatice K; Copur, Betul; Yazla, Meltem; Zerdali, Esra; Nakir, Inci Y; Cinar, Ayse RK; Buyukyazgan, Ahmet; Balli, Hatice; Kurekci, Yesim; Simsek-Yavuz, Serap; Sonmez, Mehmet M; Sengoz, Gonul; Pehlivanoglu, Filiz
title: National Early Warning Score 2 and laboratory predictors correlate with clinical deterioration in hospitalized patients with COVID-19
date: 2021-07-21
journal: Biomarkers in medicine
DOI: 10.2217/bmm-2021-0061
sha: f47441f5f73b97a4205210d487747ef50e1aa734
doc_id: 993152
cord_uid: hqvujid3

AIM: We aimed to determine the prognostic values of the National Early Warning Score 2 (NEWS2) and laboratory parameters during the first week of COVID-19. MATERIALS & METHODS: All adult patients who were hospitalized for confirmed COVID-19 between 11 March and 11 May 2020 were retrospectively included. RESULTS: Overall, 611 patients were included. Our results showed that NEWS2, procalcitonin, neutrophil/lymphocyte ratio and albumin at D0, D3, D5 and D7 were the best predictors for clinical deterioration defined as a composite of ICU admission during hospitalization or in-hospital death. Procalcitonin had the highest odds ratio for clinical deterioration on all days. CONCLUSION: This study provides a list of several laboratory parameters correlated with NEWS2 and potential predictors for clinical deterioration in patients with COVID-19.

Epidemiological and demographic characteristics, clinical, laboratory, radiological findings and outcomes were collected from medical records. Vital signs including respiratory rate, peripheral capillary oxygen saturation, heart rate, blood pressure, body temperature and consciousness (Glasgow coma scale) were recorded. Laboratory parameters including albumin, C-reactive protein (CRP), procalcitonin, hemoglobin, hematocrit, neutrophil count, lymphocyte count, platelet count, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), urea, ferritin, albumin, fibrinogen, D-dimer, aspartate aminotransferase (AST) and alanin aminotransferase at D0, D3, D5 and D7 were included. The NEWS2 score was calculated at D0, D3, D5 and D7. These parameters were obtained at the same time.

Quantitative variables are expressed as mean and standard deviation when they contain continuous and normal distributed data. When the data were not distributed normally, median and interquartile range (IQR) were used. When they contained categorical data, they were expressed as a percentage (%) and frequency (n). Comparison of qualitative variables was performed by Pearson's Chi-square test. The normal distribution questioning the necessity of using the parametric test was examined by Kolmogrov-Smirnov, Shapiro-Wilk, Kurtosis-Skewness tests and box plot distribution. When normally distributed data could not be determined, nonparametric tests and spearman correlation were used. Kruskal-Wallis test was used for the analysis of continuous and more than two independent nonparametric groups (Bonferroni correction was used when necessary) and Mann-Whitney test was used for post hoc analysis. To evaluate the factors in prognosis which were admission ICU and in-hospital death, univariate logistic regression analysis was performed. Afterward, these dependent groups were handled one by one, receiver operating characteristic (ROC) curves were drawn and cut-off values, sensitivity and specificity and area under the curve (AUC) were demonstrated. To predict clinical deterioration, the prognostic accuracy of NEWS2 and laboratory parameters at D0, D3, D5 and D7 was evaluated by ROC analyses.

• NEWS2 and laboratory parameters at D0; • NEWS2 and laboratory parameters at D3 after excluding from the analysis patients with clinical deterioration within the first 3 days of hospitalization; • NEWS2 and laboratory parameters at D5 after excluding from the analysis patients with clinical deterioration within the first 5 days of hospitalization; • NEWS2 and laboratory parameters at D7 after excluding from the analysis patients with clinical deterioration within the first 7 days of hospitalization.

Additionally, the association of the parameters at admission with the clinical deterioration was evaluated to predict the 3-day, 5-day and 7-day end points by ROC analyses.

The results were evaluated in 95% CI and statistical significance level was defined as p < 0.05. The analyzes were performed using IBM SPSS-21 (Statistical Package for Social Sciences, IL, USA) .

Overall, 611 patients were included. Of whom, 329 (53.8%) were male, the mean age was 52.53 ± 15.07 years. Seventy-three patients (11.9%) were admitted to the ICU. In-hospital death occurred in 46 (7.5%) patients. Among 73 patients (11.9%) admitted to the ICU, 40 patients (54.8%) died during hospitalization. Clinical deterioration was observed in 79 patients (12.9%) during hospitalization, 36 (5.9%), during the first 3 days, 54 (8.8%) during the first 5 days and 62 (10.1%) during the first week of hospitalization. NEWS2 was calculated at D0, D3, D5 and D7 of hospitalization. Patients were stratified into three risk groups: low risk from zero to four; medium risk from five to six and high risk above seven. Of 611 patients, 505 (82.7%) at D0, 411 (91.9%) at D3, 375 (92.2%) at D5, 284 (93.8%) at D7 had a NEWS2 score <7. The median length of hospital stay was 8.9 days and 332 patients (54.3%) who did not have fever and did not need oxygen in the last 48-72 h and meet the criteria for home monitoring were discharged within the first 7 days. Demographic characteristics of hospitalized patients with COVID-19 are available in Supplementary Table 1 .

The parameters associated with admission ICU and in-hospital death at D0, D3, D5 and D7 were NEWS2, lymphocyte count, neutrophil count, platelet count, NLR, PLR, CRP, procalcitonin, D-dimer, troponin, AST, urea, lactate dehydrogenase (LDH) and albumin. The median and IQR values of the laboratory parameters and NEWS2 are represented in Table 1 .

In univariate analysis, among parameters associated with ICU admission or in-hospital death at D0, D3, D5 and D7, best predictors were NEWS2, procalcitonin, NLR and albumin. Additionally, D-dimer (at D0, D3 and D7) and hemoglobin (at D3 and D5) were valuable predictors in univariate analysis (Table 2) .

Laboratory parameters correlated with NEWS2 at D0, D3, D5 and D7 were lymphocyte count, neutrophil count, NLR, PLR, CRP, procalcitonin, ferritin and urea (Figures 1 & 2) . ROC curves ROC curves of NEWS2 at D0, D3, D5 and D7 to predict clinical deterioration are shown in Figure 3 . AUC curves at D0, D3, D5 and D7 were 0.726, 0.798, 0.833 and 0.842, respectively (all p < 0.001).

ROC curves of procalcitonin at D0, D3, D5 and D7 to predict clinical deterioration are shown in Figure 4 . AUC curves at D0, D3, D5 and D7 were 0.824, 0.896, 0.967 and 0.823, respectively (all p < 0.001; p < 0.001; p < 0.001; p = 0.004, respectively).

ROC curves of albumin at D0, D3, D5 and D7 to predict clinical deterioration are shown in Figure 5 . AUC curves at D0, D3, D5 and D7 were 0.746, 0.868, 0.887 and 0.896, respectively (all p < 0.001).

ROC curves of NLR ratio at D0, D3, D5 and D7 to predict clinical deterioration are shown in Figure 6 . AUC curves at D0, D3, D5 and D7 were 0.752, 0.893, 0.939 and 0.911, respectively (all p < 0.001).

The combined parameter of procalcitonin, NLR, albumin and NEWS2 at D0, D3, D5 and D7 to predict clinical deterioration yielded an increased AUC of 0.838 (95% CI: 0.702-0.883; p < 0.001), 0.947 (95% CI: 0.906-0.988; p < 0.001), 0.989 (95% CI: 0.967-1.000; p < 0.001) and 0.868 (95% CI: 0.647-1.000; p = 0.035), respectively. The sensitivities and specificities of combined use were 70.4 and 88.1 at D0, 95.2 and 82.5 at D3, 83.3 and 98.9 at D5, 66.7 and 97.4% at D7, respectively.

Additionally, we analyzed the association of NEWS2, procalcitonin, albumin and NLR at admission with the end point events at D3, D5 and D7. Albumin was the best predictor for the 3-day end-point. AUC was 0.849 (95% CI: 0.755-0.944), sensitivity of 84.1% and specificity of 72.2% (p < 0.001). Procalcitonin was the best predictor for the 5-day and 7-day end points. AUC was 0.835 (95% CI: 0.748-0.821), with a sensitivity of 79.2 and specificity of 77.1% (p < 0.001) for the 5 

In this study, we presented a detailed analysis of the NEWS2 score and laboratory parameters in hospitalized patients with COVID-19. Our results showed that NEWS2, procalcitonin, NLR and albumin at D0, D3, D5, and D7 were the best predictors for clinical deterioration (ICU admission or in-hospital death Early and accurate discrimination of need for ICU improves the clinical course of COVID-19 and reduce unnecessary use of ICU beds. There are several published studies on the use of NEWS2 in COVID-19 patients [2] [3] [4] [7] [8] [9] [10] [11] [12] [13] . However, most studies evaluate NEWS2 at admission only [11] [12] [13] . In the study of Sze et al., they suggested that NEWS2 score was not a valuable tool to predict clinical deterioration in elderly patients with COVID-19 [14] . However, they reported the results of only 17 elderly patients. Kim et al. showed that NEWS2 scores on D0 significantly differed in noncritical and critical patients (2.6 ± 2.6 vs 8.2 ± 3.3; p < 0.001) [9] . In the study of Volff et al. the AUC value of NEWS score to predict ICU admission or death was 0.74, in consistent with our result. However, the AUC values of NEWS2 at D3, D5 and D7 were 0.798, 0.833 and 0.842 whereas NEWS2 at D0 was not accurate (AUC <0.750) [7] . Similarly, Sixt et al. showed that AUC values of NEWS2 was 0.74 at D0, with a best cutoff of six and was 0.98 at D7, with a best cut off of seven. They reported high sensitivity and specificity at D7 (92 and 97%, respectively) [8] .

Due to the physiopathological changes, deterioration in different laboratory parameters occurs while the disease progresses. Therefore, laboratory parameters are commonly used for assessing disease severity. Lagadinou et al. found an association between the severity of COVID-19 and the following laboratory parameters NLR, LDH, D-dimers, CRP, fibrinogen and ferritin [15] . In the study of Xu et al. procalcitonin, CRP and NLR were valuable predictors for COVID-19 mortality. They showed that the AUC from highest to lowest was combined effect >CRP >procalcitonin >NLR, respectively [16] . Liao et al. reported that NLR, thrombocytopenia, prothrombin time and D-dimer were associated with death. They showed that increased NLR (≥9·13) was associated with fivefold increased mortality risk [17] . Similarly, in our study, increased NLR was associated with 1.3-fold at D0, 1.8-fold at D3, 1.8-fold at D5 and 1.3-fold at D7 increased mortality risk in univariate analysis. In a meta-analysis, Elshazli et al. demonstrated that higher levels of leukocyte (OR: 5.21), neutrophil (OR: 6.25), D-dimer (OR: 4.19) and prolonged PT (OR: 2.18) was associated with ICU admission. IL-6 (OR: 13.87), CRP (OR: 7.09), D-dimer (OR: 6.36), and neutrophils (OR: 6.25) had the highest ORs for mortality [18] . In a meta-analysis, Lippi et al. showed that increased procalcitonin values are associated with a nearly fivefold higher risk for need for ICU or use of mechanical ventilation (OR: 4.76; 95% CI: 2.74-8.29) [19] . Xu et al. found that procalcitonin (≥0.10 ng/ml, HR: 12.82), CRP (≥52.14 mg/l, HR: 12.30) and NLR (≥3.59, HR: 8.6) had higher HRs of 12.82, 12.30 and 8.6 for mortality, respectively. Additionally, procalcitonin (≥0.10 ng/ml) and CRP (≥52.14 mg/l), but not NLR exhibited independent increasing risks of mortality, with HRs of 52.68 (95% CI: 1.77-1571.66) and 5.47 (95% CI: 1.04-28.72), respectively [16] .

In the study of Shang et al. Spearman's rank correlation analysis revealed that leukocyte, neutrophil, CRP, procalcitonin and LDH were positively correlated and albumin was negatively correlated with mortality in patients with receiving maintenance hemodialysis. Additionally, they showed that CRP had the highest AUC value (0.895) and the values of AUC of neutrophil count, LDH, leukocyte, albumin and procalcitonin were 0.813, 0.758, 0.757, 0.743 and 0.728, respectively [20] . In contrast, we found that procalcitonin was the best predictor for clinical deterioration our study. The optimal cut-off value of procalcitonin at D0, D3, D5 and D7 were 0.065, 0.125, 0.155 and 0.120 ng/ml and the sensitivity and specificity to predict clinical deterioration were 81.1 and 67.9% on D0, 80.6 and 89.3% on D3, 87.5 and 96.7% on D5 and 85.7 and 88.2% on D7, respectively. Procalcitonin is not well studied for COVID-19 cases. However, some studies suggested that increased procalcitonin levels were found to be associated with the disease severity in patients with COVID-19. A meta-analysis future science group www.futuremedicine.com showed that severe patients with COVID-19 had increased procalcitonin levels [18, 19] . Similarly, we found that procalcitonin was the best prognostic parameter for the clinical deterioration in our study. Elevated procalcitonin levels could be associated with acute secondary bacterial pneumonia or systemic secondary bacterial infection in patients with COVID-19 due to the production and release into the circulation from procalcitonin-producing extrathyroidal tissues [21] . In our study, despite elevated procalcitonin levels, this elevation was limited (the cut- off values were less than 0.5 ng/ml). In a previous study by Xu et al., they suggested that a limited increase in procalcitonin levels (cut-off value = 0.1 ng/ml) could be associated with increased IFN-γ [16] .

Low-serum albumin levels in studies with COVID-19 patients are suggested to be associated with an increased risk of mortality [22] [23] [24] [25] . In consistent with other studies, our results confirm that albumin is a valuable predictor for ICU admission or in-hospital death. Albumin is a negative acute phase reactant produced in the liver, and causes downregulation of the expression of angiotensin-converting enzyme-2 receptors, which play a role in the cell entry mechanism of SARS-CoV-2. Liu et al. reported that albumin was associated with clinical deterioration and significantly higher in patients with the improvement/stabilization than in those with disease progression (36.62 ± 6.60 vs 41.27 ± 4.55 g/l, p = 0.006) [24] 3.50 g/dl (CI: 3.26-3.74 g/dl) in the severe group and 4.05 g/dl (CI: 3.82-4.27 g/dl) in the nonsevere group (p < 0.001). They reported that hypoalbuminemia was associated with 12.6-fold increased risk of mortality [25] . An increase in neutrophils and a decrease in lymphocytes have been found in various studies. Some studies have shown that NLR may be an important indicator for the severity of COVID-19 patients. Yan et al. showed that NLR was significantly correlated with all-cause in-hospital mortality (OR: 44.351; 95% CI: 4.627-425.088) [26] . The NLR reflects the balance between the innate and adaptive immune systems [26] and increased NLR levels were found to be associated with clinical deterioration in COVID-19 [15] [16] [17] [18] 26] .

This study has several limitations. First, it was retrospectively conducted in a single center. Second, this study had a small sample size and a control group was not included. The generalizability of our results may be limited. Thus, we need new large scale studies providing important information to better understand COVID-19 pandemic. Our study has also several strengths. First, we were able to admit all critically ill patients requiring intensive care to the ICU during the first months of pandemic. This prevents a selection bias. Second, longitudinal evaluation of the association between clinical deterioration and the dynamic changes of laboratory parameters was performed, since we regularly monitored laboratory parameters during the clinical course.

This study provides a list of several laboratory parameters correlated with NEWS2 and potential predictors for ICU admission or in-hospital death during the clinical course of COVID-19. NEWS2, procalcitonin, NLR and albumin have a high accuracy to predict clinical outcomes/disease progression in hospitalized patients and should future science group www.futuremedicine.com be considered in the clinical decision of ICU admission. In conclusion, dynamic monitoring of NEWS2 and laboratory parameters is vital for improving clinical outcomes.

To view the supplementary data that accompany this paper please visit the journal website at:

www.futuremedicine.com/doi/suppl/10.2217/bmm-2021-0061 G Tuncer proposed the concept, designed the study, wrote the protocol and managed the study. G Tuncer, S Surme, IY Nakir and M Yazla, performed the statistics, interpreted the data and wrote the manuscript. S Surme, A Buyukyazgan, AK Cinar, B

Copur, E Zerdali, G Tuncer, H Balli, IY Nakir, M Yazla, Y Kurekci were involved in collecting the data. MM Sonmez, S S-Yavuz, F Pehlivanoglu, G Sengoz performed a critical review of the manuscript. All authors provided inputs for revision of the manuscript. S Surme communicated with the journal and addressed comments from reviewers. All authors contributed to data acquisition, data analysis or data interpretation and reviewed and approved the final version.

day-5 (D5) and day-7 (D7) were National Early Warning Score 2 (NEWS2), lymphocyte count, neutrophil count, platelet count, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), C-reactive protein (CRP), procalcitonin, D-dimer, troponin, aspartate aminotransferase, urea, lactate dehydrogenase and albumin. • Laboratory parameters

• Procalcitonin had the highest odds ratio for clinical deterioration on all days

• Receiver operating characteristic analyses showed that NEWS2 at D7, procalcitonin at D5, albumin at D7 and NLR at D5 had highest area under the curve values

• In univariate analysis, among parameters associated with ICU admission or in-hospital death at D0, D3, D5 and D7

This study provides a list of several laboratory parameters correlated with NEWS2 and potential predictors for ICU admission or in-hospital death during the clinical course of COVID-19

COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients ınfected with SARS-CoV-2 admitted to ICUs of the Lombardy region

Association between National Early Warning Scores in primary care and clinical outcomes: an observational study in UK primary and secondary care

NEWS (or NEWS2) score when assessing possible COVID-19 patients in primary care? Cent

NEWS) 2: standardising the assessment of acute-illness severity in the NHS

The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19

No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients

The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials

Reveals that National Early Warning Score2 at day-7 had high sensitivity and specificity for clinical deterioration

Prognostic accuracy of the SIRS, qSOFA, and NEWS for early detection of clinical deterioration in SARS-CoV-2 infected patients

Prognostic accuracy of the SIRS, qSOFA, and NEWS for early detection of clinical deterioration in SARS-CoV-2 ınfected patients

National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 -a prospective cohort study. Scand

SIRS and NEWS for predicting inhospital mortality and ICU admission in emergency admissions treated as sepsis

Letter to the Editor: variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19

States that National Early Warning Score 2 was not a valuable tool to predict clinical deterioration in elderly patients with COVID-19. However, they had a small sample size

Prognosis of COVID-19: changes in laboratory parameters

Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China

C-reactive protein (CRP) and neutrophil/lymphocyte ratio (NLR) as valuable predictors for COVID-19 mortality

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: a meta-analysis of 6320 patients

Demonstrates that higher levels of leukocyte, neutrophil, D-dimer and prolonged PT was associated with intensive care unit admission. IL-6, CRP, D-dimer and neutrophils had the highest odds ratio for mortality

Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis

Correlation between laboratory parameters on admission and outcome of COVID-19 in maintenance hemodialysis patients

Reveals that leukocyte, neutrophil, CRP, procalcitonin and lactate dehydrogenase were positively correlated and albumin was negatively correlated with mortality in COVID-19 patients with receiving maintenance hemodialysis

Laboratory abnormalities in patients with COVID-2019 infection

Liver injury during highly pathogenic human coronavirus infections

Gemelli against COVID-19" group. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

• Reports that albumin was associated with clinical deterioration and significantly higher in patients with the improvement/stabilization than in those with disease progression

The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis

Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: a retrospective cross-sectional study

The authors acknowledge all the healthcare professionals who contribute to the care of our patients.

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.

The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.